United States (US) Oral Anti-Diabetic Drug Market (2025-2031) | Industry, Share, Forecast, Companies, Segmentation, Competitive Landscape, Analysis, Outlook, Value, Size & Revenue, Trends, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Oral Anti-Diabetic Drug Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Oral Anti-Diabetic Drug Market - Industry Life Cycle

3.4 United States (US) Oral Anti-Diabetic Drug Market - Porter's Five Forces

3.5 United States (US) Oral Anti-Diabetic Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes in the United States

4.2.2 Growing awareness about the importance of managing diabetes through medication

4.2.3 Technological advancements in oral anti-diabetic drugs leading to improved efficacy and convenience

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval and marketing

4.3.2 Competition from alternative treatments such as insulin therapy

4.3.3 Rising concerns about potential side effects and long-term health implications of oral anti-diabetic drugs

6.1 United States (US) Oral Anti-Diabetic Drug Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 United States (US) Oral Anti-Diabetic Drug Market Revenues & Volume, By Drugs, 2021- 2031F

6.1.3 United States (US) Oral Anti-Diabetic Drug Market Revenues & Volume, By Biguanides, 2021- 2031F

6.1.4 United States (US) Oral Anti-Diabetic Drug Market Revenues & Volume, By Alpha-glucosidase inhibitors, 2021- 2031F

6.1.5 United States (US) Oral Anti-Diabetic Drug Market Revenues & Volume, By Dopamine-D2 receptor agonists, 2021- 2031F

6.1.6 United States (US) Oral Anti-Diabetic Drug Market Revenues & Volume, By Sodium-glucose Cotransport-2 (SGLT-2) inhibitor, 2021- 2031F

6.1.7 United States (US) Oral Anti-Diabetic Drug Market Revenues & Volume, By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, 2021- 2031F

6.1.8 United States (US) Oral Anti-Diabetic Drug Market Revenues & Volume, By Sulfonylureas, 2021- 2031F

7.1 United States (US) Oral Anti-Diabetic Drug Market Export to Major Countries

7.2 United States (US) Oral Anti-Diabetic Drug Market Imports from Major Countries

8.1 Patient adherence rate to oral anti-diabetic drug treatment

8.2 Number of new oral anti-diabetic drug approvals by regulatory authorities

8.3 Rate of adoption of novel drug delivery technologies in oral anti-diabetic drugs

9.1 United States (US) Oral Anti-Diabetic Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F

10.1 United States (US) Oral Anti-Diabetic Drug Market Revenue Share, By Companies, 2024

10.2 United States (US) Oral Anti-Diabetic Drug Market Competitive Benchmarking, By Operating and Technical Parameters